Amplify Weight Loss Drug & Treatment ETF (THNR) Dividend Yield, History & Forecast

Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. The most recent ex-dividend date was December 30, 2025, with payment scheduled for December 31, 2025. market capitalization is approximately $3M.

Frequently Asked Questions about Amplify Weight Loss Drug & Treatment ETF (THNR)

When does Amplify Weight Loss Drug & Treatment ETF pay distributions?
The most recent ex-dividend date was December 30, 2025. The next scheduled dividend payment date is December 31, 2025.
How many years has Amplify Weight Loss Drug & Treatment ETF increased its dividend?
Amplify Weight Loss Drug & Treatment ETF (THNR) has increased its dividend for 1 consecutive year.
What does Amplify Weight Loss Drug & Treatment ETF invest in?
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.